QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.71%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.64 (-0.03%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.71%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.64 (-0.03%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.71%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.64 (-0.03%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.71%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.64 (-0.03%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Immunome (IMNM) Short Interest Ratio & Short Volume

$23.25
+1.24 (+5.63%)
(As of 04:25 PM ET)

Immunome Short Interest Data

Current Short Volume
3,410,000 shares
Previous Short Volume
1,990,000 shares
Change Vs. Previous Month
+71.36%
Dollar Volume Sold Short
$56.50 million
Short Interest Ratio / Days to Cover
9.2
Last Record Date
January 31, 2024
Outstanding Shares
54,750,000 shares
Percentage of Shares Shorted
6.23%
Today's Trading Volume
563,465 shares
Average Trading Volume
759,385 shares
Today's Volume Vs. Average
74%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Immunome ?

Sign up to receive the latest short interest report for Immunome and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IMNM Short Interest Over Time

IMNM Days to Cover Over Time

IMNM Percentage of Float Shorted Over Time


Immunome Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20243,410,000 shares $56.50 million +71.4%N/A9.2 $16.57
1/15/20241,990,000 shares $26.19 million +8.2%N/A8.7 $13.16
12/31/20231,840,000 shares $19.69 million +171.4%N/A11.1 $10.70
12/15/2023678,100 shares $5.11 million +24.6%N/A5.1 $7.54
11/30/2023544,100 shares $4.06 million +27.1%N/A7.9 $7.46
11/15/2023428,200 shares $3.40 million +96.4%N/A7.4 $7.95
10/31/2023218,000 shares $1.92 million +10.3%N/A4.6 $8.80
10/15/2023197,700 shares $1.78 million -10.3%N/A4.5 $8.99
9/30/2023220,500 shares $1.84 million -3.0%2.9%4.5 $8.35
9/15/2023227,200 shares $1.65 million +5.3%2.7%0.9 $7.26
8/31/2023215,800 shares $1.39 million +0.1%2.6%0.9 $6.45
8/15/2023215,500 shares $1.61 million -11.7%2.6%0.9 $7.45
7/31/2023244,000 shares $1.75 million +17.4%2.9%1 $7.16
7/15/2023207,800 shares $1.61 million +70.9%2.6%0.8 $7.77
6/30/2023121,600 shares $961,856.00 -14.9%1.5%0.5 $7.91
6/15/2023142,900 shares $763,086.00 -3.1%1.5%5 $5.34
5/31/2023147,500 shares $772,900.00 +5.9%1.5%4.7 $5.24
5/15/2023139,300 shares $866,446.00 -30.0%1.5%4.1 $6.22
4/30/2023198,900 shares $952,731.00 +8.6%2.1%5.6 $4.79
4/15/2023183,200 shares $883,024.00 +12.6%1.9%4.5 $4.82
3/31/2023162,700 shares $811,873.00 +25.6%1.7%3.2 $4.99
3/15/2023129,500 shares $609,945.00 -11.2%1.4%1.5 $4.71
2/28/2023145,800 shares $666,306.00 +9.3%1.5%1.7 $4.57
2/15/2023133,400 shares $729,698.00 +0.9%1.4%1.6 $5.47
1/31/2023132,200 shares $699,338.00 +15.9%1.4%1.7 $5.29
1/15/2023114,100 shares $456,400.00 +117.8%1.2%1.6 $4.00
12/30/202252,400 shares $115,804.00 -13.8%0.6%0.9 $2.21
12/15/202260,800 shares $234,080.00 -20.3%0.6%3.6 $3.85
11/30/202276,300 shares $329,997.50 +14.1%0.8%5 $4.33
11/15/202266,900 shares $278,304.00 +43.9%0.7%4 $4.16
10/31/202246,500 shares $202,740.00 +10.2%0.5%2.3 $4.36
10/15/202242,200 shares $200,872.00 -8.7%0.4%1.8 $4.76
9/30/202246,200 shares $205,128.00 +9.7%0.5%1.9 $4.44
9/15/202242,100 shares $214,289.00 +7.4%0.4%1.2 $5.09
8/31/202239,200 shares $225,008.00 -0.3%0.4%1.1 $5.74
8/15/202239,300 shares $208,290.00 -13.8%0.4%1 $5.30
7/31/202245,600 shares $177,156.00 -13.0%0.5%1 $3.89
7/15/202252,400 shares $205,932.00 -6.4%0.6%0.9 $3.93
6/30/202256,000 shares $179,760.00 +12.7%0.6%0.8 $3.21
6/15/202249,700 shares $147,609.00 -41.0%0.5%0.6 $2.97













IMNM Short Interest - Frequently Asked Questions

What is Immunome's current short interest?

Short interest is the volume of Immunome shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 3,410,000 shares of IMNM short. Learn More on Immunome's current short interest.

What is a good short interest ratio for Immunome?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMNM shares currently have a short interest ratio of 9.0. Learn More on Immunome's short interest ratio.

Which institutional investors are shorting Immunome?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunome: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Immunome's short interest increasing or decreasing?

Immunome saw a increase in short interest in January. As of January 31st, there was short interest totaling 3,410,000 shares, an increase of 71.4% from the previous total of 1,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Immunome's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immunome: Amylyx Pharmaceuticals, Inc. (10.94%), Zentalis Pharmaceuticals, Inc. (19.26%), Innoviva, Inc. (19.24%), MannKind Co. (12.98%), Arcturus Therapeutics Holdings Inc. (17.95%), Avidity Biosciences, Inc. (10.31%), Centessa Pharmaceuticals plc (1.90%), Cassava Sciences, Inc. (31.83%), IGM Biosciences, Inc. (22.49%), Pliant Therapeutics, Inc. (10.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Immunome stock?

Short selling IMNM is an investing strategy that aims to generate trading profit from Immunome as its price is falling. IMNM shares are trading up $1.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunome?

A short squeeze for Immunome occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMNM, which in turn drives the price of the stock up even further.

How often is Immunome's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMNM, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:IMNM) was last updated on 2/22/2024 by MarketBeat.com Staff